VRCA · Categories · Form 4

VRCA - SEC Form 4 insider transactions

Verrica Pharmaceuticals Inc. (VRCA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for VRCA

• 155d
  Interim CFO Kirby John J. was granted 10,000 shares, increasing direct ownership by 112% to 18,962 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 359d
  SEC Form 4 filed by Director Nguyen Diem

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 359d
  SEC Form 4 filed by Director Corcoran Gavin

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 359d
  SEC Form 4 filed by Director Prygocki Mark A Sr

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 359d
  SEC Form 4 filed by Director Eichenfield Lawrence

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 427d
  SEC Form 4 filed by Director Corcoran Gavin

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 434d
  SEC Form 4 filed by CMO Rosenberg Noah L.

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 442d
  CHIEF LEGAL OFFICER Hayes Christopher G. sold $2,805 worth of shares (4,315 units at $0.65), decreasing direct ownership by 2% to 176,458 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 442d
  SEC Form 4 filed by CEO and President Rieger Jayson

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 482d
  Amendment: Chief Medical Officer Goldenberg Gary was granted 50,000 shares, increasing direct ownership by 71% to 120,110 units (SEC Form 4)

  4/A - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 482d
  Amendment: CHIEF LEGAL OFFICER Hayes Christopher G. was granted 150,000 shares, increasing direct ownership by 183% to 231,925 units (SEC Form 4)

  4/A - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 482d
  Amendment: PRESIDENT AND CEO White Ted was granted 150,000 shares, increasing direct ownership by 116% to 278,789 units (SEC Form 4)

  4/A - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 482d
  Amendment: CHIEF FINANCIAL OFFICER Kohler Terry was granted 125,000 shares (SEC Form 4)

  4/A - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 482d
  Amendment: CHIEF COMMERCIAL OFFICER Bonaccorso Joe was granted 125,000 shares, increasing direct ownership by 199% to 187,738 units (SEC Form 4)

  4/A - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 541d
  SEC Form 4 filed by Chief Operating Officer Zawitz David

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 573d
  Interim CFO Kirby John J. was granted 54,267 shares (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 573d
  SEC Form 4 filed by CEO and President Rieger Jayson

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 600d
  SEC Form 4 filed by CHIEF LEGAL OFFICER Hayes Christopher G.

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 618d
  Director Manning Paul B gifted 2,675,611 shares and received a gift of 2,675,611 shares (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 644d
  CHIEF LEGAL OFFICER Hayes Christopher G. sold $93,091 worth of shares (35,713 units at $2.61), decreasing direct ownership by 25% to 105,773 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 644d
  CHIEF FINANCIAL OFFICER Kohler Terry sold $77,473 worth of shares (29,719 units at $2.61), decreasing direct ownership by 40% to 44,697 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 644d
  CHIEF COMMERCIAL OFFICER Bonaccorso Joe sold $87,849 worth of shares (33,702 units at $2.61), decreasing direct ownership by 32% to 73,114 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 644d
  Chief Medical Officer Goldenberg Gary sold $35,161 worth of shares (13,489 units at $2.61), decreasing direct ownership by 13% to 94,261 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 644d
  PRESIDENT AND CEO White Ted sold $88,636 worth of shares (34,000 units at $2.61), decreasing direct ownership by 14% to 215,967 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 680d
  PRESIDENT AND CEO White Ted sold $230,306 worth of shares (32,623 units at $7.06), decreasing direct ownership by 12% to 249,967 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 680d
  CHIEF COMMERCIAL OFFICER Bonaccorso Joe sold $180,557 worth of shares (25,576 units at $7.06), decreasing direct ownership by 19% to 106,816 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 680d
  Chief Medical Officer Goldenberg Gary sold $130,653 worth of shares (18,507 units at $7.06), decreasing direct ownership by 15% to 107,750 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 680d
  CHIEF LEGAL OFFICER Hayes Christopher G. sold $153,477 worth of shares (21,740 units at $7.06), decreasing direct ownership by 13% to 141,486 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 726d
  SEC Form 4 filed by Nguyen Diem

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 726d
  SEC Form 4 filed by Eichenfield Lawrence

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 726d
  SEC Form 4 filed by Ballaron Craig

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 726d
  SEC Form 4 filed by Prygocki Mark A Sr

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 806d
  White Ted was granted 112,500 shares, increasing direct ownership by 66% to 282,590 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 806d
  Kohler Terry was granted 40,000 shares, increasing direct ownership by 116% to 74,416 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 806d
  Hayes Christopher G. was granted 40,000 shares, increasing direct ownership by 32% to 163,226 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 806d
  Goldenberg Gary was granted 40,000 shares, increasing direct ownership by 46% to 126,257 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 806d
  Bonaccorso Joe was granted 40,000 shares, increasing direct ownership by 43% to 132,392 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 930d
  Bonaccorso Joe sold $96,689 worth of shares (32,846 units at $2.94), decreasing direct ownership by 26% to 92,392 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 930d
  Goldenberg Gary sold $26,061 worth of shares (8,853 units at $2.94), decreasing direct ownership by 9% to 86,257 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 930d
  Kohler Terry sold $82,671 worth of shares (28,084 units at $2.94), decreasing direct ownership by 45% to 34,416 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 930d
  White Ted sold $99,200 worth of shares (33,699 units at $2.94), decreasing direct ownership by 17% to 170,090 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 930d
  Hayes Christopher G. sold $99,200 worth of shares (33,699 units at $2.94), decreasing direct ownership by 21% to 123,226 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1010d
  SEC Form 4: Hayes Christopher G. was granted 75,000 shares, increasing direct ownership by 92% to 156,925 units

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1010d
  SEC Form 4: White Ted was granted 75,000 shares, increasing direct ownership by 58% to 203,789 units

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1010d
  SEC Form 4: Kohler Terry was granted 62,500 shares

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1010d
  SEC Form 4: Bonaccorso Joe was granted 62,500 shares, increasing direct ownership by 100% to 125,238 units

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1010d
  SEC Form 4: Goldenberg Gary was granted 25,000 shares, increasing direct ownership by 36% to 95,110 units

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1044d
  SEC Form 4 filed by Hayes Christopher G.

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1044d
  SEC Form 4 filed by Goldenberg Gary

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1044d
  SEC Form 4 filed by Bonaccorso Joe

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1044d
  SEC Form 4 filed by White Ted

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1045d
  SEC Form 4 filed by Manning Paul B

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1087d
  SEC Form 4 filed by Ballaron Craig

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1087d
  SEC Form 4 filed by Eichenfield Lawrence

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1087d
  SEC Form 4 filed by Nguyen Diem

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1087d
  SEC Form 4 filed by Prygocki Mark A Sr

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1198d
  SEC Form 4: White Ted bought $15,750 worth of shares (7,500 units at $2.10), increasing direct ownership by 34% to 29,466 units (Amendment)

  4/A - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1423d
  SEC Form 4: Hayes Christopher G. bought $25,500 worth of shares (7,500 units at $3.40), increasing direct ownership by 91% to 15,714 units

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1429d
  SEC Form 4: Perceptive Advisors Llc bought $2,999,999 worth of shares (1,428,571 units at $2.10)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 1429d
  SEC Form 4: Hayes Christopher G. bought $11,999 worth of shares (5,714 units at $2.10), increasing direct ownership by 229% to 8,214 units

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)

Other VRCA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends